Targeting Distal Lung High-potential sales opportunity exists in expanding adoption of the i·Logic System’s Electromagnetic Navigation Bronchoscopy (ENB) capabilities to diagnose and treat distal lung disease, particularly where traditional bronchoscopy falls short.

Accessibility Expansion Focus on markets and hospitals seeking less invasive diagnostic options for deep lung lesions and mediastinal lymph nodes to reduce reliance on high-risk procedures and improve patient care pathways.

Capital and Consumables Leverage the combined sale of capital equipment and disposables to drive recurring revenue through consumables tied to the i·Logic System, creating long-term customer relationships.

Global Footprint Target international expansion initiatives given headquarters in the US with offices in Germany and Israel, identifying regional partners and distributors to accelerate market entry.

Financial and Growth Levers Position partnerships and funding conversations around a scalable platform with a sizable total addressable market, emphasizing upgrade paths, training, and site-level efficiency gains to attract hospital investment.